Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 507

The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.

Sarcopenia in chronic kidney disease: what have we learned so far?

Open access
Sabatino, Alice, Cuppari, Lilian, Stenvinkel, Peter, Lindholm, Bengt, Avesani, Carla Maria·2021·Journal of Nephrology

Abstract

The term sarcopenia was first introduced in 1988 by Irwin Rosenberg to define a condition of muscle loss that occurs in the elderly. Since then, a broader definition comprising not only loss of muscle mass, but also loss of muscle strength and low physical performance due to ageing or other conditions, was developed and published in consensus papers from geriatric societies. Sarcopenia was proposed to be diagnosed based on operational criteria using two components of muscle abnormalities, low muscle mass and low muscle function. This brought awareness of an important nutritional derangement with adverse outcomes for the overall health. In parallel, many studies in patients with chronic kidney disease (CKD) have shown that sarcopenia is a prevalent condition, mainly among patients with end stage kidney disease (ESKD) on hemodialysis (HD). In CKD, sarcopenia is not necessarily age-related as it occurs as a result of the accelerated protein catabolism from the disease and from the dialysis procedure per se combined with low energy and protein intakes. Observational studies showed that sarcopenia and especially low muscle strength is associated with worse clinical outcomes, including worse quality of life (QoL) and higher hospitalization and mortality rates. This review aims to discuss the differences in conceptual definition of sarcopenia in the elderly and in CKD, as well as to describe etiology of sarcopenia, prevalence, outcome, and interventions that attempted to reverse the loss of muscle mass, strength and mobility in CKD and ESKD patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40620-020-00840-y

Cites

175 of 175 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 175 references

Research works printed but not linked: 12

  1. Deleaval P, Luaire B, Laffay P, Jambut-Cadon D, Stauss-Grabo M, Canaud B, Chazot C (2020) Short-term effects of branched-chain amino acids-enriched dialysis fluid on branched-chain amino acids plasma level and mass balance: a randomized cross-over study. J Ren Nutr. https://doi.org/10.1053/j.jrn.2019.03.079 · doi:10.1053/j.jrn.2019.03.079
  2. Martins A, Dias-Rodrigues J, de Oliveira-Santin F, Barbosa-Brito FDS, Bello-Moreira A, Lourenço R, Avesani C (2015) Food intake assessment of elderly patients on hemodialysis. J Ren Nutr. https://doi.org/10.1053/j.jrn.2014.10.007 · doi:10.1053/j.jrn.2014.10.007
  3. Choi JS, Kim YA, Kang YU, Kim CS, Bae EH, Ma SK, Ahn YK, Jeong MH, Kim SW (2013) Clinical impact of hospital-acquired anemia in association with acute kidney injury and chronic kidney disease in patients with acute myocardial infarction. PLoS ONE 8(9):e75583. https://doi.org/10.1371/journal.pone.0075583 · doi:10.1371/journal.pone.0075583
  4. Molsted S, Bjørkman A, Lundstrøm L (2019) Effects of strength training to patients undergoing dialysis: a systematic review. Dan Med J 66(1):A5526
  5. Acchiardo S, Moore L, Cockrell S (1982) Effect of essential amino acids (EAA) on chronic hemodialysis (CHD) patients (PTS). Trans Am Soc Artif Intern Organs 28:608–614
  6. Chazot C, Shahmir E, Matias B, Laidlaw S, Kopple J (1997) Dialytic nutrition: provision of amino acids in dialysate during hemodialysis. Kidney Int. https://doi.org/10.1038/ki.1997.500 · doi:10.1038/ki.1997.500
  7. Cupisti A, Bolasco P (2017) Keto-analogues and essential aminoacids and other supplements in the conservative management of chronic kidney disease. Panminerva Med. https://doi.org/10.23736/S0031-0808.16.03288-2 · doi:10.23736/s0031-0808.16.03288-2
  8. Claro L, Moreno-Amaral A, Gadotti A, Dolenga C, Nakao L, Azevedo M, de Noronha L, Olandoski M, de Moraes T, Stinghen A, Pécoits-Filho R (2018) The Impact of uremic toxicity induced inflammatory response on the cardiovascular burden in chronic kidney disease. Toxins. https://doi.org/10.3390/toxins10100384 · doi:10.3390/toxins10100384
  9. Panorchan K, Nongnuch A, El-Kateb S, Goodlad C, Davenport A (2015) Changes in muscle and fat mass with haemodialysis detected by multi-frequency bioelectrical impedance analysis. Eur J Clin Nutr. https://doi.org/10.1038/ejcn.2015.90 · doi:10.1038/ejcn.2015.90
  10. Kang S, Cho K, Park J, Yoon K, Do J (2014) Body composition measurements using bioimpedance analysis in peritoneal dialysis patients are affected by the presence of dialysate. Nephrology. https://doi.org/10.1111/nep.12322 · doi:10.1111/nep.12322
  11. Pinto A, Ramos C, Meireles M, Kamimura M, Cuppari L (2015) Impact of hemodialysis session on handgrip strength. J Bras Nefrol. https://doi.org/10.5935/0101-2800.20150072 · doi:10.5935/0101-2800.20150072
  12. da Silva M, Vogt B, Reis N, Caramori J (2019) Update of the European consensus on sarcopenia: what has changed in diagnosis and prevalence in peritoneal dialysis? Eur J Clin Nutr. https://doi.org/10.1038/s41430-019-0468-z · doi:10.1038/s41430-019-0468-z

Cited by

See all 507

Metadata

Authors
Sabatino, A., Cuppari, L., Stenvinkel, P., Lindholm, B., & Avesani, C. M.
Venue
Journal of Nephrology
Published
2020-09-02
Volume
34
Issue
4
Pages
1347-1372
ISSN
  • 1121-8428 (ISSN-L)
  • 1724-6059
OpenAlex
W3082064123
Cited by
507
References
175
FWCI
31.68
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
Karolinska Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sarcopenia in chronic kidney disease: what have we learned so far? https://app.cochat.ai/papers/10.1007/s40620-020-00840-y
The paper
Sabatino, A., Cuppari, L., Stenvinkel, P., Lindholm, B., & Avesani, C. M. (2021). Sarcopenia in chronic kidney disease: what have we learned so far? Journal of Nephrology. https://doi.org/10.1007/s40620-020-00840-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.